Role of Ulinastatin, a trypsin inhibitor, in severe acute pancreatitis in critical care setting: A retrospective analysis

Journal of Critical Care

Volumn 45, Issue , 2018, Pages 27-32

  Lagoo, Jui Yeshavant ^a   D'Souza, Moses Charles ^a   Kartha, Anandajith ^b   Kutappa, Appanervanda Muthanna ^c  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^b AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

^c Advanced Neurosciences Institute BGS Global Hospital   (India)

Author keywords

Acute pancreatitis; Mortality; Organ dysfunction; Ulinastatin

Indexed keywords

CREATININE; ULINASTATIN; GLYCOPROTEIN; TRYPSIN INHIBITOR;

ACUTE PANCREATITIS; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLASGOW COMA SCALE; HOSPITAL MORTALITY; HUMAN; INDIA; INTENSIVE CARE; KIDNEY FAILURE; LENGTH OF STAY; LIVER DYSFUNCTION; MALE; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SURGICAL INTENSIVE CARE UNIT; ACUTE DISEASE; PANCREATITIS; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; CRITICAL CARE; FEMALE; GLYCOPROTEINS; HUMANS; LENGTH OF STAY; MALE; PANCREATITIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRYPSIN INHIBITORS;

EID: 85044519098     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2018.01.021     Document Type: Article

References (31)

1. IAP, W.G., Guidelines, A.A., IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology, 13(4, 2013 Aug 31, e1-5.
2. Dumnicka, P., Maduzia, D., Ceranowicz, P., Olszanecki, R., Drożdż R., Kuśnierz-Cabala, B., The interplay between inflammation, coagulation and endothelial injury in the early phase of acute pancreatitis: clinical implications. Int J Mol Sci, 18(2), 2017 Feb 8, 354.
3. Yadav, D., Lowenfels, A.B., The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 144:6 (2013 May 31), 1252–1261.
4. Afghani, E., Pandol, S.J., Shimosegawa, T., Sutton, R., Wu, B.U., Vege, S.S., et al. Acute pancreatitis—progress and challenges: a report on an international symposium. Pancreas, 44(8), 2015 Nov, 1195.
5. Janisch, N.H., Gardner, T.B., Advances in management of acute pancreatitis. Gastroenterol Clin North Am 45:1 (2016 Mar 31), 1–8.
6. Bendersky, V.A., Mallipeddi, M.K., Perez, A., Pappas, T.N., Necrotizing pancreatitis: challenges and solutions. Clin Exp Gastroenterol, 9, 2016, 345.
7. Mole, D.J., Olabi, B., Robinson, V., Garden, O.J., Parks, R.W., Incidence of individual organ dysfunction in fatal acute pancreatitis: analysis of 1024 death records. HPB 11:2 (2009 Mar 1), 166–170.
8. Arlt, A., Erhart, W., Schafmayer, C., Held, H.C., Hampe, J., Antibiosis of necrotizing pancreatitis. Visceral Medicine 30:5 (2014 Oct 7), 318–324.
9. Banks, P.A., Bollen, T.L., Dervenis, C., Gooszen, H.G., Johnson, C.D., Sarr, M.G., et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut 62:1 (2013 Jan 1), 102–111.
10. Greenberg, J.A., Hsu, J., Bawazeer, M., Marshall, J., Friedrich, J.O., Nathens, A., et al. Clinical practice guideline: management of acute pancreatitis. Can J Surg, 59(2), 2016 Apr, 128.
11. Meher, S., Mishra, T.S., Sasmal, P.K., Rath, S., Sharma, R., Rout, B., et al. Role of biomarkers in diagnosis and prognostic evaluation of acute pancreatitis. J. Biomarkers, 2015, 2015 Aug 5.
12. Bruno, M.J., Dutch Pancreatitis Study Group, Improving the outcome of acute pancreatitis. Dig Dis 34:5 (2016 Jun 23), 540–545.
13. Srinivasan, G., Venkatakrishnan, L., Sambandam, S., Singh, G., Kaur, M., Janarthan, K., et al. Current concepts in the management of acute pancreatitis. J Family Med Prim Care, 5(4), 2016 Oct, 752.
14. Huan, C., Kim, D., Ou, P., Alfonso, A., Stanek, A., Mechanisms of interleukin-22's beneficial effects in acute pancreatitis. World J Gastrointest Pathophysiol, 7(1), 2016 Feb 15, 108.
15. Kitagawa, M., Hayakawa, T., Antiproteases in the treatment of acute pancreatitis. JOP 8:4 Suppl (2007 Jul 9), 518–525 (Online).
16. Dellinger, R.P., Levy, M.M., Rhodes, A., Annane, D., Gerlach, H., Opal, S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39:2 (2013 Feb 1), 165–228.
17. Surati, K., Suthar, K., Shah, J., Parekh, B., A study of recent trends in acute pancreatitis. Int J Med Sci Public Health 3 (2014), 63–68.
18. Yang, Z.W., Meng, X.X., Xu, P., Central role of neutrophil in the pathogenesis of severe acute pancreatitis. J Cell Mol Med 19:11 (2015 Nov 1), 2513–2520.
19. Schouten, M., Wiersinga, W.J., Levi, M., Van Der Poll, T., Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 83:3 (2008 Mar 1), 536–545.
20. Chen, C.C., Wang, S.S., Lee, F.Y., Action of antiproteases on the inflammatory response in acute pancreatitis. JOP 8:4 Suppl (2007 Jul 9), 488–494.
21. Fries, E., Blom, A.M., Bikunin—not just a plasma proteinase inhibitor. Int J Biochem Cell Biol 32:2 (2000 Feb 29), 125–137.
22. Linder, A., Russell, J.A., An exciting candidate therapy for sepsis: ulinastatin, a urinary protease inhibitor. Intensive Care Med 40:8 (2014 Aug), 1164–1167.
23. Umeadi, C., Kandeel, F., Al-Abdullah, I.H., Ulinastatin is a novel protease inhibitor and neutral protease activator. Transplantation Proceedings, 2008 Mar 31, Elsevier (Vol. 40, No. 2, pp. 387-389).
24. Tani, S., Otsuki, M., Itoh, H., Nakamura, T., Fujii, M., Okabayashi, Y., et al. The protective effect of the trypsin inhibitor urinastatin on cerulein-induced acute pancreatitis in rats. Pancreas 3:4 (1988 Aug 1), 471–476.
25. Hirano, T., Manabe, T., Human urinary trypsin inhibitor, urinastatin, prevents pancreatic injuries induced by pancreaticobiliary duct obstruction with cerulein stimulation and systemic hypotension in the rat. Arch Surg 128:12 (1993 Dec 1), 1322–1329.
26. Maciejewski, R., Burdan, F., Burski, K., Madej, B., Ziemiakowicz, R., Dąbrowski, A., et al. Selected biochemical parameters and ultrastructural picture of pancreas due to ulinastatin treatment of experimental acute pancreatitis. Exp Toxicol Pathol 56:4 (2005 Mar 21), 305–311.
27. Wallner, G., Solecki, M., Ziemiakowicz, R., et al. Morphological changes of the pancreas in course of acute pancreatitis during treatment with ulinastatin. Pol Przegl Chir 85:3 (2013), 114–122.
28. Zhang, C., Wang, Y., Fu, W., Zhang, W., Wang, T., Qin, H., A meta-analysis on the effect of ulinastatin on serum levels of C-reactive protein, interleukin 6, and tumor necrosis factor alpha in Asian patients with acute pancreatitis. Genet Test Mol Biomarkers 20:3 (2016 Mar 1), 118–124.
29. Abraham, P., Rodriques, J., Moulick, N., Dharap, S., Chafekar, N., Verma, P.K., et al. Efficacy and safety of intravenous ulinastatin versus placebo along with standard supportive care in subjects with mild or severe acute pancreatitis. J Assoc Physicians India 61:8 (2013 Aug), 535–538.
30. Pandol, S.J., Saluja, A.K., Imrie, C.W., Banks, P.A., Review in basic and clinical gastroenterology. Gastroenterology 132 (2007), 1127–1151.
31. Johnson, C.D., Abu-Hilal, M., Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Gut 53:9 (2004 Sep 1), 1340–1344.